Stock Market Reviews

OFIX (Orthofix Medical Inc.) News

Get the latest news, insights, and market updates on OFIX (Orthofix Medical Inc.). Explore the news page 1 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.

• Orthofix Medical Inc. (NASDAQ:OFIX) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
  Orthofix Medical Inc. ( NASDAQ:OFIX ) shareholders are probably feeling a little disappointed, since its shares fell...
  Nov 7, 2025 - $OFIX
• Orthofix Medical (OFIX): Losses Deepen, Undervalued Stock Tests Bullish Recovery Narratives
  Orthofix Medical (OFIX) reported ongoing losses, with net profit margins failing to improve and losses increasing at an average annual rate of 42.7% over the past five years. Despite these challenges, revenue is expected to grow at 4.8% per year, which remains well below the broader US market’s anticipated growth of 10.5%. Investors appear cautious, but the stock is currently trading at $14.87, significantly below the estimated fair value of $25.85 and at a price-to-sales ratio of just 0.7x...
  Nov 5, 2025 - $OFIX
• Orthofix Medical Inc (OFIX) Q3 2025 Earnings Call Highlights: Strong Growth in US Spine and ...
  Orthofix Medical Inc (OFIX) reports robust revenue growth and continued EBITDA margin expansion, while navigating pricing pressures and distributor transitions.
  Nov 4, 2025 - $OFIX
• Orthofix: Q3 Earnings Snapshot
  LEWISVILLE, Texas (AP) — Orthofix Medical Inc. OFIX) on Tuesday reported a loss of $22.8 million in its third quarter. On a per-share basis, the Lewisville, Texas-based company said it had a loss of 57 cents.
  Nov 4, 2025 - $OFIX
• Orthofix (OFIX) Beats Q3 Earnings and Revenue Estimates
  Orthofix (OFIX) delivered earnings and revenue surprises of +66.67% and +2.65%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
  Nov 4, 2025 - $OFIX
• Orthofix Reports Third Quarter 2025 Financial Results
  LEWISVILLE, Texas, November 04, 2025--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today reported its financial results for the third quarter ended September 30, 2025, narrowed its full-year 2025 net sales guidance while maintaining the midpoint, and raised the low end of its adjusted EBITDA guidance. All pro forma measures contained within this release exclude the impact of the Company’s decision to discontinue its M6™ product lines.
  Nov 4, 2025 - $OFIX
• Astria, Viridian Therapeutics, and More Stocks See Action From Activist Investors
  13D FILINGS These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity’s attaining more than 5% in any class of a company’s securities.
  Oct 31, 2025 - $OFIX
• Is There Now An Opportunity In Orthofix Medical Inc. (NASDAQ:OFIX)?
  While Orthofix Medical Inc. ( NASDAQ:OFIX ) might not have the largest market cap around , it received a lot of...
  Oct 28, 2025 - $OFIX
• Orthofix to Participate in Upcoming Investor Conferences
  LEWISVILLE, Texas, October 15, 2025--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that Massimo Calafiore, President and Chief Executive Officer, and Julie Andrews, Chief Financial Officer, will participate in the following investor conferences:
  Oct 15, 2025 - $OFIX
• Orthofix to Report Third Quarter 2025 Financial Results
  LEWISVILLE, Texas, October 14, 2025--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that it will release its third quarter 2025 financial results on Tuesday, November 4, 2025, before market open. The Company will host a conference call and webcast to review results at 8:30 am Eastern Time the same day.
  Oct 14, 2025 - $OFIX